By Bart Bogacz
Publication Date: 2025-12-12 01:44:00
Image source: Getty Images
Investors in Artrya Ltd (ASX: AYA) have had a turbulent ride over the last few months.
Just over a year ago, shares in this ASX AI share were changing hands for $0.46 apiece.
Today, Artrya shares hit a new all-time high of $4.29 in morning trading before falling back down to $3.92 apiece at the time of writing.
This powerful rally represents a stunning 752% return in just twelve months and is blowing the broader market out of the water.
For context: the Index of all ordinaries (ASX:XAO) is up 4.53% over the same period.
So what’s behind this remarkable achievement?
Let’s take a closer look at what’s driving the heat for this ASX AI share.
Improving the diagnosis of heart disease
Founded in 2019, Artrya is a medical technology company that markets cloud-based AI solutions for heart disease diagnostics.
Its flagship platform, Salix, enables rapid assessment of chest pain in emergency and primary care settings.
Management believes Salix can help patients…